Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Tiens Group, operating primarily through its subsidiary Tianjin Tianshi Biological Development, is a global conglomerate specializing in the research, development, and manufacturing of health supplements and wellness products. Founded in 1995 and headquartered in Tianjin, China, the company integrates Traditional Chinese Medicine (TCM) principles with modern biotechnology to produce a wide range of nutraceuticals, including calcium supplements, herbal teas, and immune-boosting extracts. Tiens is widely recognized for its extensive direct-selling (MLM) network, which distributes products to millions of consumers across more than 190 countries. Beyond healthcare, the company has diversified into retail, tourism, and e-commerce, maintaining a significant presence in international markets.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Dongfeng Tianshi Biological Development.